Trial Profile
GO2 - Alternative chemotherapy for frail or elderly patients with advanced gastric or oesophageal cancer: a randomised controlled trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2022
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms GO2
- 04 Jun 2019 Results of a substudy presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 04 Aug 2017 Planned End Date changed from 31 Oct 2016 to 31 Dec 2018.